» Articles » PMID: 9952216

Relationship of Extraintestinal Involvements in Inflammatory Bowel Disease: New Insights into Autoimmune Pathogenesis

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1999 Feb 10
PMID 9952216
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Extraintestinal manifestations in patients with inflammatory bowel disease (IBD) are quite common (about 25%) and careful clinical observation and statistical analysis during the last five decades have demonstrated that in colitis-associated extraintestinal complications, the organs most commonly involved are the biliary tract, joints, skin, and eyes. However, almost all organs can be involved in IBD. Some of the extraintestinal manifestations may precede IBD, although the majority accompany the underlying disease and are influenced by its activity. Prompt recognition of extracolonic organ involvement in IBD is important because of the relative refractoriness of the disease and a possible increase in morbidity and mortality. The identified pathogenetic autoimmune mechanisms include genetic susceptibility, cytokine imbalances, antigenic display of autoantigen, aberrant self-recognition, and immunopathogenetic autoantibodies against organ-specific cellular antigen(s) shared by colon and extracolonic organs. Microbes may play an important role, probably by molecular mimicry.

Citing Articles

The causal effects of inflammatory bowel disease on its ocular manifestations: A Mendelian randomization study.

Luo L, Tang X, Xu J, Bao Y, Hu X, Zhong X PLoS One. 2025; 20(3):e0316437.

PMID: 40072972 PMC: 11902285. DOI: 10.1371/journal.pone.0316437.


Diabetes mellitus, metformin's target gene AMPK, and inflammatory bowel disease: A Mendelian randomization study.

Wu W, Tong H, Li Y, Cui J Medicine (Baltimore). 2025; 104(7):e41532.

PMID: 39960958 PMC: 11835072. DOI: 10.1097/MD.0000000000041532.


Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.

Lewandowski K, Kaniewska M, Karlowicz K, Wiecek M, Tulewicz-Marti E, Celmer P Prz Gastroenterol. 2025; 16(4):397-407.

PMID: 39810871 PMC: 11726220. DOI: 10.5114/pg.2024.144988.


Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It.

Migliorisi G, Vella G, Dal Buono A, Gabbiadini R, Busacca A, Loy L Cells. 2024; 13(2).

PMID: 38247834 PMC: 10814681. DOI: 10.3390/cells13020142.


Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD.

Alizadeh M, Motwani K, Siaton B, Abutaleb A, Ravel J, Cross R Inflamm Bowel Dis. 2023; 30(11):2027-2036.

PMID: 38102817 PMC: 11532592. DOI: 10.1093/ibd/izad280.


References
1.
Gregory B, Ho V . Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol. 1992; 26(3 Pt 2):371-83. DOI: 10.1016/0190-9622(92)70059-o. View

2.
Yeatman N, SACHS J, Bottazzo G . Autoimmunity--towards the year 2001. Immunol Today. 1992; 13(7):239-40. DOI: 10.1016/0167-5699(92)90001-N. View

3.
Halstensen T, Mollnes T, Garred P, Fausa O, Brandtzaeg P . Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. Gut. 1992; 33(7):902-8. PMC: 1379402. DOI: 10.1136/gut.33.7.902. View

4.
BROBERGER O, Perlmann P . Autoantibodies in human ulcerative colitis. J Exp Med. 1959; 110:657-74. PMC: 2137024. DOI: 10.1084/jem.110.5.657. View

5.
BROBERGER O, Perlmann P . In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures. J Exp Med. 1963; 117:705-16. PMC: 2137646. DOI: 10.1084/jem.117.5.705. View